HCV Core Protein 抗体 (Cy7)
-
- 抗原 See all HCV Core Protein (HCV C) 抗体
- HCV Core Protein (HCV C) (Hepatitis C Virus Core Protein (HCV C))
-
适用
- Hepatitis C Virus (HCV)
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This HCV Core Protein antibody is conjugated to Cy7
-
应用范围
- Western Blotting (WB)
- 交叉反应
- 人, Virus
- 交叉反应 （详细）
- HCV
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from HCV-Core
- 亚型
- IgG
- Top Product
- Discover our top product HCV C Primary Antibody
-
anti-Hepatitis C Virus Core Protein (HCV C) (AA 13-124), (AA 369-704) antibody (Biotin)
HCV C 适用: Hepatitis C Virus (HCV) ELISA, WB, IF, IHC 宿主: 小鼠 Monoclonal H6-29 Biotin
anti-Hepatitis C Virus Core Protein (HCV C) (AA 13-124), (AA 369-704) antibody (FITC)HCV C 适用: Hepatitis C Virus (HCV) IF, IHC 宿主: 小鼠 Monoclonal H6-29 FITC
anti-Hepatitis C Virus Core Protein (HCV C) antibodyHCV C 适用: Hepatitis C Virus (HCV) WB 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- IF(IHC-P) 1:50-200
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- 有效期
- 12 months
-
- 抗原
- HCV Core Protein (HCV C) (Hepatitis C Virus Core Protein (HCV C))
- 别名
- HCV Core Protein (HCV C 产品)
- 物质类
- Viral Protein
- 背景
-
Synonyms: Core protein p19, Hepatitis C Virus Core Antigen-C, HCVAg, HCV-Core protein,HCV core antigen, HCV core protein, Hepatitis C Virus core protein, capsid protein, polyprotein precursor, Core protein p21, Core protein p9.
Background: Core protein packages viral RNA to form a viral nucleocapsid, and promotes virion budding. Modulates viral translation initiation by interacting with HCV IRES and 40S ribosomal subunit. Also regulates many host cellular functions such as signaling pathways and apoptosis. Prevents the establishment of cellular antiviral state by blocking the interferon-alpha/beta (IFN-alpha/beta) and IFN-gamma signaling pathways and by inducing human STAT1 degradation. Plays an important role in virus-mediated cell transformation leading to hepatocellular carcinomas. Interacts with, and activates STAT3 leading to cellular transformation. May repress the promoter of p53, and sequester CREB3 and SP110 isoform3/Sp110b in the cytoplasm. Also represses cell cycle negative regulating factor CDKN1A, thereby interrupting an important check point of normal cell cycle regulation. Targets transcription factors involved in the regulation of inflammatory responses and in the immune response: suppresses NK-kappaB activation, and activates AP-1. Mediates apoptotic pathways throught association with TNF-type receptors TNFRSF1A and LTBR, although its effect on death receptors-induced apoptosis remains controvertial. Enhances TRAIL mediated apoptosis, suggesting that it might play a role in mediated apoptosis, suggesting that it might play a role in immune-mediated liver cell injury. Secreted core protein is able to bind C1QR1 at the T-cell surface, resulting in down-regulation of T-lymphocytes proliferation. May transactivate human MYC, Rous sarcoma virus LTR, and SV40 promoters. May suppress the human FOS and HIV-1 LTR activity. May alter lipid metabolism by interacting with hepatocellular proteins involved in lipid accumulation and storage.
- UniProt
- P26664
-
